STC1 levels in the supernatant of MSCs + AML groups ranged between 0.5 and 1.15 ng/mL, showing an up to 10-fold increase compared with MSCs + CD34+ cells alone (0.035–0.4 ng/mL) (Figure 3B). The gene discussed is STC1; the disease is acute myeloid leukemia.